Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol
- 1School of Exercise and Health, Shanghai University of Sport, Shanghai, China
- 2College of Physical Education and Health, Shanghai Business School, Shanghai, China
Abstract
Background: Mild cognitive impairment (MCI) is a prevalent complication of type 2 diabetes mellitus (T2DM). Cognitive impairment progressively impairs self-care abilities, thereby triggering a vicious cycle of poor glycemic control and further cognitive decline. Exercise has been widely recognized as an effective strategy to improve both glycemic control and cognitive function; however, an optimal time of day for exercise to mitigate this neurodegenerative trajectory has not been determined. This trial aims to determine the most effective exercise timing to maximize cognitive benefits in older T2DM patients with MCI (T2DM-MCI) and to investigate the underlying neurobiological mechanisms using multimodal magnetic resonance imaging. Methods: In this randomized controlled trial, patients 60–75 years of age with T2DM‐MCI will be assigned to a morning exercise group (09:00–10:10), an evening exercise group (19:00–20:10), or a health education group. The exercise groups will complete a 12-week, home-based, remotely supervised exercise program comprising aerobic and resistance exercises. The health education group will receive a 12-week health education program. Cognitive function will be evaluated at baseline and post-intervention using the Montreal Cognitive Assessment, Color-Word Stroop Test, N-back task, Trail making Test, Attention Network Test, and Digit Symbol Substitution Test. Additionally, brain structure and function based on imaging, blood biomarkers, and physical fitness will also be assessed. Discussion: In this study, we aim to identify the optimal time of day for exercise to maximize cognitive benefits in patients with T2DM‐MCI and to elucidate underlying neurocognitive mechanisms. We will examine whether glycemic control mediates the relationship between exercise and cognitive function improvement. This research is expected to provide “time-specific” evidence for exercise prescription to maximize the neurocognitive benefits and mitigate dementia risk in this population. Trial registration: Chinese Clinical Trial Registry: [http://www.chictr.org.cn], identifier [ChiCTR2300073737].
Related
- Long-chain Omega-3 fatty acids supplementation and cognitive performance throughout adulthood: A 6-month randomized controlled trial.
- Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice
- Atypical Chemokine Receptor DARC/ACKR1 Is Expressed Selectively by Neurons with Regional Heterogeneity and Protects against Neuroinflammation and Cognitive Impairment
- Dementia Language Models: a generalizable and controllable representation of cognitive impairment
- Distance-dependent Functional Connectivity Strength Analysis Using Resting-State fMRI: Application to Vascular Cognitive Impairment, No Dementia
BibTeX
@article{lin2026effects,
title = {{Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol}},
author = {Yanyu Lin and Zhiying Ma and Jinghua Zhang and Jie Zhuang},
journal = {PLOS One},
year = {2026},
month = nov,
doi = {10.1371/journal.pone.0361868},
url = {https://doi.org/10.1371/journal.pone.0361868},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Effects and mechanisms of exercise timing on cognitive function in older type 2 diabetes mellitus patients with mild cognitive impairment: A magnetic resonance imaging-based randomized controlled trial protocol
AU - Yanyu Lin
AU - Zhiying Ma
AU - Jinghua Zhang
AU - Jie Zhuang
PY - 2026
DA - 2026/11/04
JO - PLOS One
DO - 10.1371/journal.pone.0361868
UR - https://doi.org/10.1371/journal.pone.0361868
AB - Background: Mild cognitive impairment (MCI) is a prevalent complication of type 2 diabetes mellitus (T2DM). Cognitive impairment progressively impairs self-care abilities, thereby triggering a vicious cycle of poor glycemic control and further cognitive decline. Exercise has been widely recognized as an effective strategy to improve both glycemic control and cognitive function; however, an optimal time of day for exercise to mitigate this neurodegenerative trajectory has not been determined. This trial aims to determine the most effective exercise timing to maximize cognitive benefits in older T2DM patients with MCI (T2DM-MCI) and to investigate the underlying neurobiological mechanisms using multimodal magnetic resonance imaging. Methods: In this randomized controlled trial, patients 60–75 years of age with T2DM‐MCI will be assigned to a morning exercise group (09:00–10:10), an evening exercise group (19:00–20:10), or a health education group. The exercise groups will complete a 12-week, home-based, remotely supervised exercise program comprising aerobic and resistance exercises. The health education group will receive a 12-week health education program. Cognitive function will be evaluated at baseline and post-intervention using the Montreal Cognitive Assessment, Color-Word Stroop Test, N-back task, Trail making Test, Attention Network Test, and Digit Symbol Substitution Test. Additionally, brain structure and function based on imaging, blood biomarkers, and physical fitness will also be assessed. Discussion: In this study, we aim to identify the optimal time of day for exercise to maximize cognitive benefits in patients with T2DM‐MCI and to elucidate underlying neurocognitive mechanisms. We will examine whether glycemic control mediates the relationship between exercise and cognitive function improvement. This research is expected to provide “time-specific” evidence for exercise prescription to maximize the neurocognitive benefits and mitigate dementia risk in this population. Trial registration: Chinese Clinical Trial Registry: [http://www.chictr.org.cn], identifier [ChiCTR2300073737].
SN - 1932-6203
ER -